
New real-world studies show Vraylar boosts depression relief, functioning, and quality of life in MDD and bipolar I patients beyond clinical trials.
What are the guidelines for working with patients who do not respond to FDA-approved medications for bipolar disorder?
Which of the following interventions can be useful in treating treatment-resistant bipolar disorder?